Effector conjugates, process for their production and their pharmaceutical use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 26, 2008
Grant Date -
Apr 19, 2007
app pub date -
Aug 25, 2006
filing date -
Jul 31, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully